NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.
Novabridge Biosciences stock last closed at $4.27, down 9.63% from the previous day, and has increased 291.74% in one year. It has overperformed other stocks in the Biotechnology industry by 3.51 percentage points. Novabridge Biosciences stock is currently +617.65% from its 52-week low of $0.60, and -37.11% from its 52-week high of $6.79.
At the moment, there are 188.11M NBP shares outstanding. The market value of NBP is $349.40M. In the last 24 hours, 673,000 NBP shares were traded.
How to Buy Novabridge Biosciences Stock
Wondering how to invest in Novabridge Biosciences stock? Here's how.
Decide where to buy Novabridge Biosciences stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you choose where to buy Novabridge Biosciences stock.
Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Deposit funds into your brokerage account: Pick your payment method and add your information.
Research Novabridge Biosciences stock: The Novabridge Biosciences ticker symbol is NBP. Is Novabridge Biosciences stock a good investment? Should you buy shares of NBP? How do NBP's underlying business fundamentals look? Do top analysts think Novabridge Biosciences is a good buy? Why has NBP's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if NBP is a good stock to buy).
Execute your NBP buy order: Decide if you will purchase NBP shares at the current market price or use a limit order to purchase NBP shares at a particular price.
Get the latest scoop on your NBP position: Create a watchlist to track your investment in Novabridge Biosciences stock.
Step 1: Decide where to buy Novabridge Biosciences stock
You will need a brokerage account in order to access the NASDAQ market and buy NBP shares.
A brokerage account enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to global financial markets: From Tech to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've chosen the best brokerage, you'll need to fill out some personal details so you are able to buy NBP today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Novabridge Biosciences stock
After you have chosen the best place to buy Novabridge Biosciences stock, it's critical to evaluate their stock before you invest, so you actually wrap your head around the risk and opportunity.
Novabridge Biosciences Numbers
NBP Price
$4.27
1w %
-7.97%
1y %
291.74%
5y %
-88.54%
P/E
-8.84x
P/B
1.78x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$38.21M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$349.40M
Next Earnings
Nov 13, 2025
Next Dividend
N/A
NBP Fundamentals
WallStreetZen was designed to help everyday investors perform more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on NBP's stock page.
Is NBP stock properly valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge NBP's fair value.
Using relative valuations ratios:
NBP may be undervalued based on its P/B ratio of 1.78x, relative to Biotechnology industry P/B ratio of 4.87x
Last year, NBP revenue was $0.00. During the past five year, NBP's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 72.87%.
No, Novabridge Biosciences doesn't provide an income stream by paying out dividends.
What do other investors have to say about NBP?
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your NBP buy order
There are two main options:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are usually the easiest way to buy.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a particular dollar amount, use a limit order.
Press the Open button and eToro will execute the order.
If you require additional assistance investing in stocks on eToro, click the helpful video below:
How much does it cost to buy one Novabridge Biosciences share?
As of Nov 4, 2025, it costs $4.27 to buy one share of Novabridge Biosciences stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $2, you can buy 0.468 shares of NBP.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.